Assessing Response for Nivolumab Plus Ipilimumab in Squamous Cell Carcinoma of the Head and Neck.

Klein, Oliver

Klein, Oliver.

Affiliation

Klein O; Olivia Newton-John Cancer Research Institute, Olivia Newton-John Cancer Centre, Austin Health, Heidelberg, Victoria, Australia.

JAMA Oncol ; 10(1): 143-144, 2024 Jan 01.

Article in En | MEDLINE | ID: mdl-37991743

Subject(s)

Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Kidney Neoplasms; Humans; Nivolumab/therapeutic use; Ipilimumab/adverse effects; Squamous Cell Carcinoma of Head and Neck/drug therapy; Carcinoma, Squamous Cell/diagnostic imaging; Carcinoma, Squamous Cell/drug therapy; Kidney Neoplasms/drug therapy; Head and Neck Neoplasms/diagnostic imaging; Head and Neck Neoplasms/drug therapy; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell/drug therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Carcinoma, Squamous Cell / Head and Neck Neoplasms / Kidney Neoplasms Limits: Humans Language: En Journal: JAMA Oncol Year: 2024 Document type: Article

Fulltext

XML

PubMed Links

Search on Google